Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Medical Informed Consent topic
No spam. Unsubscribe anytime.
Committee defers SB 107 on medical informed‑consent after concerns of duplication and stakeholder comments
Summary
SB 107, which would alter standards for medical informed consent, drew opposition or comments from the Hawaii Medical Board and major health associations; the committee deferred the measure as duplicative of existing law.
The Senate Committee on Health and Human Services deferred SB 107, a proposal to amend medical informed‑consent standards, after multiple medical organizations registered opposition or raised concerns that the bill duplicates existing law.
Chelsea Fukunaga, executive officer of the Hawaii Medical Board, told the committee the board formally opposed the bill and said it would sign onto written testimony opposing the measure. Representatives from Queen’s Health Systems and the Healthcare Association of Hawaii stood on submitted comments, raising concerns about duplication and potential conflicts with existing standards.
Public testimony included suggestions to clarify how consent processes should account for combined mental and physical health conditions. Angela Melody of Young Roar Care suggested amendments to account for primary and secondary health conditions and to require coordination between mental‑health and physical‑health providers in informed‑consent standards.
Committee action: After hearing the testimony and noting overlapping standards already present in law, the chair recommended deferral; the committee deferred SB 107 as duplicative and to allow stakeholders time to reconcile standards.
Next steps: The committee expects interested parties to propose clarifying amendments and to return the bill with specific, non‑duplicative language if they wish to pursue the measure further.
